"L-Carnitine Supplementation in Recovery after Exercise." National Library of Medicine
H., and Teijink, J
According to the findings, people covered by Medicaid or Medicare, Black patients, and those who experienced nausea or other gastrointestinal side effects (37%) were more likely to discontinue a GLP-1 medication within the first year
Two realities now coexist: (i) unprecedented demand, and (ii) supply strain not just on drug substance, but also on delivery systems (pens, autoinjectors, fill-finish). He further stresses that, Device capacity is a real bottleneck: pen bodies, springs, needles, cartridges, and aseptic fillfinish all sit on long lead times and specialized lines
The first type is called humectants: these ingredients help attract water
The other is creating GLP1like effects without raising the peptide itself